APLS
Apellis Pharmaceuticals Inc

3,704
Mkt Cap
$2.52B
Volume
2.26M
52W High
$31.17
52W Low
$16.10
PE Ratio
67.16
APLS Fundamentals
Price
$19.94
Prev Close
$20.53
Open
$20.53
50D MA
$22.63
Beta
1.02
Avg. Volume
2.25M
EPS (Annual)
-$1.60
P/B
6.29
Rev/Employee
$1.1M
Loading...
Loading...
News
all
press releases
Campbell & CO Investment Adviser LLC Invests $1.21 Million in Apellis Pharmaceuticals, Inc. $APLS
Campbell & CO Investment Adviser LLC purchased a new stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) during the third quarter, according to the company in its most recent...
MarketBeat·24h ago
News Placeholder
More News
News Placeholder
Insider Selling: Apellis Pharmaceuticals (NASDAQ:APLS) CAO Sells $19,371.87 in Stock
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) CAO James George Chopas sold 873 shares of the stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price...
MarketBeat·4d ago
News Placeholder
Apellis Pharmaceuticals (NASDAQ:APLS) Insider Pascal Deschatelets Sells 2,277 Shares
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) insider Pascal Deschatelets sold 2,277 shares of the firm's stock in a transaction that occurred on Tuesday, January 13th. The stock was...
MarketBeat·4d ago
News Placeholder
Mark Jeffrey Delong Sells 1,780 Shares of Apellis Pharmaceuticals (NASDAQ:APLS) Stock
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) insider Mark Jeffrey Delong sold 1,780 shares of the stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at...
MarketBeat·4d ago
News Placeholder
Insider Selling: Apellis Pharmaceuticals (NASDAQ:APLS) Insider Sells 2,618 Shares of Stock
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) insider Nur Nicholson sold 2,618 shares of the firm's stock in a transaction dated Tuesday, January 13th. The stock was sold at an...
MarketBeat·4d ago
News Placeholder
Insider Selling: Apellis Pharmaceuticals (NASDAQ:APLS) CFO Sells 3,856 Shares of Stock
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) CFO Timothy Eugene Sullivan sold 3,856 shares of the stock in a transaction on Tuesday, January 13th. The stock was sold at an average...
MarketBeat·4d ago
News Placeholder
David Watson Sells 5,780 Shares of Apellis Pharmaceuticals (NASDAQ:APLS) Stock
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) General Counsel David Watson sold 5,780 shares of the business's stock in a transaction that occurred on Tuesday, January 13th. The stock...
MarketBeat·4d ago
News Placeholder
Apellis Pharmaceuticals (NASDAQ:APLS) CEO Sells $226,027.34 in Stock
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) CEO Cedric Francois sold 10,186 shares of the business's stock in a transaction dated Tuesday, January 13th. The stock was sold at an...
MarketBeat·4d ago
News Placeholder
Apellis Stock Crashes 23% in a Week: Here's What You Should Know
APLS stock plunges 23% in a week after reporting $190 million in preliminary Q4 U.S. net product revenues, as weaker Syfovre sales and mixed Empaveli uptake disappoint investors.
Zacks·5d ago
News Placeholder
Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Down 5.8% on Analyst Downgrade
Apellis Pharmaceuticals (NASDAQ:APLS) Shares Down 5.8% on Analyst Downgrade...
MarketBeat·6d ago
<
1
2
...
>

Latest APLS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.